Key Details
Price
$185.38Annual Revenue
$624.80 MAnnual EPS
-$0.72PE Ratio
173.25Annual ROE
-3.96%Beta
0.84Events Calendar
Next earnings date:
Feb 06, 2025Recent quarterly earnings:
Nov 04, 2024Recent annual earnings:
Feb 06, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
BofA Securities has improved its rating for Inspire Medical Systems, Inc. (INSP) and now considers the company to be in the profitable growth sector.
MINNEAPOLIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a company that creates advanced, minimally invasive treatments for obstructive sleep apnea, has announced that its management team will speak at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.
MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a company that creates advanced, minimally invasive treatments for obstructive sleep apnea, has announced that its management team will speak at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.
Inspire Medical Systems, Inc. (NYSE:INSP) will hold its Q3 2024 Earnings Conference Call on November 4, 2024, at 5:00 PM ET. The call will feature company representatives including Ezgi Yagci, Tim Herbert, and Rick Buchholz, along with various participants from financial institutions like JPMorgan, UBS, and Bank of America Securities. The conference will be operated by Dilem, who will assist during the call.
While the revenue and earnings per share (EPS) for Inspire (INSP) provide insight into its performance for the quarter ending September 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.
Inspire Medical Systems (INSP) reported quarterly earnings of $0.60 per share, which is higher than the Zacks Consensus Estimate of $0.06 per share. This is an improvement compared to a loss of $0.29 per share from the same period last year.
Inspire has reported a 33% increase in revenue compared to last year and earnings per share of $0.60 for the third quarter. This shows strong financial performance for the company. The growth indicates a positive trend in their business.
Stocks in the Zacks Medical Info Systems sector, such as Inspire Medical Systems, 10x Genomics, and Omnicell, are likely to benefit from the rise of GenAI technology.
Inspire (INSP) has received a Zacks Rank #2 (Buy) upgrade, indicating increased confidence in the company's potential earnings. This could lead to a rise in the stock price soon.
MINNEAPOLIS, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) will announce its financial results for the third quarter of 2024 after the market closes on Monday, November 4. Following this, the management team will hold a conference call at 5:00 p.m. Eastern Time to talk about the financial results and recent updates in the business.
FAQ
- What is the primary business of Inspire Medical Systems?
- What is the ticker symbol for Inspire Medical Systems?
- Does Inspire Medical Systems pay dividends?
- What sector is Inspire Medical Systems in?
- What industry is Inspire Medical Systems in?
- What country is Inspire Medical Systems based in?
- When did Inspire Medical Systems go public?
- Is Inspire Medical Systems in the S&P 500?
- Is Inspire Medical Systems in the NASDAQ 100?
- Is Inspire Medical Systems in the Dow Jones?
- When was Inspire Medical Systems's last earnings report?
- When does Inspire Medical Systems report earnings?
- Should I buy Inspire Medical Systems stock now?